Skip to main content

Find Clinical Trials

Home
Conditions
B-Cell Non-Hodgkin Lymphoma-Refractory

Clinical trial condition

B-Cell Non-Hodgkin Lymphoma-Refractory

Explore clinical trials studying B-Cell Non-Hodgkin Lymphoma-Refractory. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

B-Cell Non-Hodgkin Lymphoma-Refractory trial results

Recruiting

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

NCT06209619

Conditions: B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory, Diffuse Large B-Cell Lymphoma-Recurrent, +9 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL

NCT06618313

Conditions: B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory
Locations: Department of Lymphoma and Myeloma, Yuhengnan Road, Changping District, Beijing Beijing, China

View Trial Details

Recruiting

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT06395870

Conditions: B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory
Locations: Oncology Department, The First Affiliated Hospital of USTC west district Hefei, Anhui, China

Tianjin Cancer Hospital Tianjin, China

View Trial Details